Understanding Prostate Cancer Mutations Is Critical

LEONARD GOMELLA, MD, FACS

Tuesday, March 19, 2019

The BRCA1 and BRCA2 genes, which have typically been associated with breast and ovarian cancer, are proving to be important in the prostate cancer space, too, said Leonard G. Gomella, MD, FACS, director of the Kimmel Cancer Center Network and chair of the department of urology at the Sidney Kimmel Cancer Center at Thomas Jefferson University.

While the genes do not seem to actually cause cancer, patients with prostate cancer who have BRCA mutations tend to have more aggressive disease, making it even more important for providers to better understand the genetic makeup of the disease.

Discussions >>

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Related Videos

Nurses Are "On the Front Lines" for Patients Treated With Radium-223

By: Rana R. McKay, MD

Investigative mCRPC Treatment Requires Team Approach

By: Emmanuel S. Antonarakis, MBBCh

Expert Discusses Genetic Predisposition to Prostate Cancer in Racially Diverse Patient Populations

By: Curtis A. Pettaway, MD